The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

DexCom Inc

Nasdaq: DXCM
Last

(U.S.) $58.45

Today's change-3.08 -5.01%
Updated December 11 4:00 PM EST. Delayed by at least 15 minutes.
 

DexCom Inc

Nasdaq: DXCM
Last

(U.S.) $58.45

Today's change-3.08 -5.01%
Updated December 11 4:00 PM EST. Delayed by at least 15 minutes.

Sharp drop following new 50-day high

DexCom Inc closed sharply lower Monday, dropping (U.S.)$3.08 or 5.01% to (U.S.)$58.45 after setting a new 50-day high. Over the last five days, shares have gained 0.98%, but are currently unchanged over the last year to date. Shares have underperformed the S&P 500 by 27.81% during the last year.

Key company metrics

  • Open(U.S.) $61.23
  • Previous close(U.S.) $61.53
  • High(U.S.) $62.35
  • Low(U.S.) $57.71
  • Bid / Ask(U.S.) $57.72 / (U.S.) $58.50
  • YTD % change-2.09%
  • Volume1,778,492
  • Average volume (10-day)2,079,183
  • Average volume (1-month)1,752,014
  • Average volume (3-month)1,927,895
  • 52-week range(U.S.) $42.62 to (U.S.) $88.80
  • Beta0.28
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$0.57
Updated December 11 4:00 PM EST. Delayed by at least 15 minutes.
S&P TSX0.05%Sector:HealthcareIndustry:Medical Equipment, Supplies & Distribution
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2017Q2/2017Q1/2017Q4/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201709/30/2017Jun 30, 201706/30/2017Mar 31, 201703/31/2017Dec 31, 201612/31/2016
Revenue185171142171
Total other revenue--------
Total revenue185171142171
Gross profit12711894117
Total cost of revenue58534855
Total operating expense185184183177
Selling / general / administrative84868679
Research & development43454844
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income-1-14-40-6
Interest income (expense), net non-operating-5-3-10
Gain (loss) on sale of assets--------
Other--------
Income before tax-3-14-40-7
Income after tax-23-42-7
Income tax, total-1-1710
Net income-23-42-7
Total adjustments to net income--------
Net income before extra. items-23-42-7
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-23-42-7
Inc. avail. to common incl. extra. items-23-42-7
Diluted net income-23-42-7
Dilution adjustment----0--
Diluted weighted average shares87868585
Diluted EPS excluding extraordinary itemsvalue per share-0.020.03-0.49-0.09
Dividends per sharevalue per share0.000.000.00--
Diluted normalized EPSvalue per share-0.020.03-0.49-0.09